SHANGHAI, China, Jan. 15, 2023 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of ...

Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ: DVAX) have executed the commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant for use in Clover's protein-based ...

CHENGDU, China, and EMERYVILLE, Calif., June 30, 2021 /PRNewswire/ -- Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic ...

Chinese clinical-stage biotech Clover Biopharmaceuticals and Nasdaq-listed Dynavax Technologies Corp, a biopharmaceutical company focused on developing and commercializing novel vaccines, announced on ...

THE Advertising Standards Authority has banned a Clover milk TV commercial that spoofs a Sasol ad positioning the petrochemical producer as an all-round technology leader. The Sasol ad is part of a ...

-- China commercial launch in multiple provinces and municipalities expected to begin in Q1 2023, and Clover anticipates a significant and sustained long-term annual booster market for its premium, ...

Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) Pending conditional regulatory approvals, Clover ...